Niagen Bioscience, Inc. (NAGE) — Cash Flow Reinvestment Rate
Niagen Bioscience, Inc. (NAGE) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $48.00K (capex $24.00K plus investments $-24.00K) from operating cash flow of $3.69 Million. See Niagen Bioscience, Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Niagen Bioscience, Inc. Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Niagen Bioscience, Inc. across 2 annual periods. For the full cash flow conversion analysis, see Niagen Bioscience, Inc. operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Niagen Bioscience, Inc. (2023–2024)
Year-by-year capital reinvestment analysis for Niagen Bioscience, Inc.. See Niagen Bioscience, Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | $306.00K | $12.11 Million | $163.00K | ▼ -38.2% |
| 2023 | 0.04x | $291.00K | $7.12 Million | $148.00K | — |